TrialJournal of clinical pharmacology2019

Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials.

Ellen van der Aar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.